1. Home
  2. HURN vs OLMA Comparison

HURN vs OLMA Comparison

Compare HURN & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huron Consulting Group Inc.

HURN

Huron Consulting Group Inc.

HOLD

Current Price

$179.87

Market Cap

2.8B

ML Signal

HOLD

Logo Olema Pharmaceuticals Inc.

OLMA

Olema Pharmaceuticals Inc.

HOLD

Current Price

$26.39

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HURN
OLMA
Founded
2002
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.6B
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
HURN
OLMA
Price
$179.87
$26.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
$199.00
$40.50
AVG Volume (30 Days)
130.3K
2.8M
Earning Date
10-28-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
32.32
N/A
EPS
5.98
N/A
Revenue
$1,618,977,000.00
N/A
Revenue This Year
$14.19
N/A
Revenue Next Year
$9.49
N/A
P/E Ratio
$30.20
N/A
Revenue Growth
12.67
N/A
52 Week Low
$120.25
$2.86
52 Week High
$182.71
$36.26

Technical Indicators

Market Signals
Indicator
HURN
OLMA
Relative Strength Index (RSI) 68.39 50.90
Support Level $178.00 $25.85
Resistance Level $181.14 $36.26
Average True Range (ATR) 4.82 2.77
MACD -0.02 -1.22
Stochastic Oscillator 90.91 6.25

Price Performance

Historical Comparison
HURN
OLMA

About HURN Huron Consulting Group Inc.

Huron Consulting Group Inc is a professional services firm. The company provides expertise in technology, operations, advisory services, & analytics through three operating segments namely Healthcare, Education, and Commercial. Healthcare segment helps the firms to transform and innovate the delivery model to focus on patient wellness by improving quality outcomes, minimizing care variation and fundamentally improving patient and population health, Education segment provides management consulting and technology solutions, and Commercial segment is focused on serving industries and organizations facing disruption and regulatory change. It generates a majority of its revenue from the Healthcare Segment.

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

Share on Social Networks: